Xconomy National

Archives

by in

Entry	Author	Date	Location
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug	Luke Timmerman	01/27/12	National
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More	Erin Kutz	01/13/12	Boston
Civitas Charts Positive Data on Inhaled Parkinson’s Drug	Arlene Weintraub	01/06/12	Boston
Zogenix Sets Timetable for New Painkiller Drug	Bruce V. Bigelow	12/20/11	San Diego
Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines	Erin Kutz	12/02/11	Boston
Rib-X, Skyhook, Michael J. Fox Foundation & More Boston-Area Deals News	Erin Kutz	11/30/11	Boston
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug	Luke Timmerman	11/29/11	Boston
Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact	Bruce V. Bigelow	11/08/11	San Diego
T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News	Erin Kutz	08/12/11	Boston
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News	Bruce V. Bigelow	08/11/11	San Diego
Bydureon FDA Deadline Set	Luke Timmerman	08/10/11	San Diego
Amylin & Takeda Halt Obesity Drug Development	Bruce V. Bigelow	08/04/11	San Diego
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News	Bruce V. Bigelow	08/04/11	San Diego
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News	Erin Kutz	07/29/11	Boston
Bydureon Sent Back to FDA	Luke Timmerman	07/28/11	San Diego
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News	Erin Kutz	07/08/11	Boston
Amylin, Alkermes Once-Weekly Diabetes Drug Passes Heart Trial Demanded by FDA	Luke Timmerman	07/07/11	San Diego
Alkermes Wins Over Investors With Plan To Become Trans-Atlantic “Big Biotech”	Luke Timmerman	07/06/11	Boston
Inception 1 Raises $5M, VCs Pessimistic About U.S. Biotech Funding, EU Approves Amylin’s Once-a-Week Diabetes Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	06/23/11	San Diego
Amylin, Alkermes Diabetes Med OKd in EU	Luke Timmerman	06/21/11	San Diego
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs	Luke Timmerman	05/25/11	Boston
Varian Bought by Applied Materials, Nuance Picks Up Equitrac, Alkermes Pays $960M for Elan Unit, & More Boston-Area Deals News	Erin Kutz	05/11/11	Boston
Alkermes Acquires Elan Drug Manufacturing Unit for $960M	Luke Timmerman	05/09/11	Boston
West Wireless Repositions Itself as an Impartial Arbiter, Amylin Makes Headway in Europe, VCs Debate Viability of Venture-Backed Biotech, & More San Diego Life Sciences News	Bruce V. Bigelow	04/21/11	San Diego
The Bob Langer and Polaris Family Tree: From Acusphere to Momenta to Visterra	Gregory T. Huang	04/19/11	Boston
Biotech’s Missed Opportunity: Small-Town and Rural America	Luke Timmerman	04/18/11	National
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug	Luke Timmerman	04/15/11	San Diego
The New Tech Bubble, Biotech Vs. Big Pharma, and More Thoughts from Boston BD Conference	Gregory T. Huang	04/14/11	Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the First Quarter	Gregory T. Huang	03/31/11	Boston
RXi Sells Stock and Warrants, Cardiorobotics Raises $6.6M, ImmunoGen Dishes On New Drugs, & More Boston-Area Life Sciences News	Erin Kutz	03/04/11	Boston
Page 1 of 4	next page »